Risk Factors for Linezolid Resistance in Staphylococcus Aureus



Status:Completed
Conditions:Infectious Disease, Hospital
Therapuetic Areas:Immunology / Infectious Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:6/14/2018
Start Date:August 2007
End Date:June 2017

Use our guide to learn which trials are right for you!

This is a retrospective chart review study. The proposed study aims to document the risk
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed.

This is a retrospective chart review study. The proposed study aims to document the risk
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed. This research is important because identification of risk factors may allow earlier
initiation of appropriate therapy in patients infected with these bacteria. Additionally, we
will identify whether horizontal spread is responsible for this increasing trend.

Inclusion Criteria:

- patients with linezolid resistance to staphylococcus aureus

Exclusion Criteria:

- those that don't meet entry criteria
We found this trial at
1
site
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials